ASSOCIATION BETWEEN THE OXIDATIVE POLYMORPHISM AND EARLY-ONSET OF PARKINSONS-DISEASE

被引:68
作者
AGUNDEZ, JAG
JIMENEZJIMENEZ, FJ
LUENGO, A
BERNAL, ML
MOLINA, JA
AYUSO, L
VAZQUEZ, A
PARRA, J
DUARTE, J
CORIA, F
LADERO, JM
ALVAREZ, JC
BENITEZ, J
机构
[1] UNIV EXTREMADURA, FAC MED, SCH MED, DEPT FARMACOL, E-06071 BADAJOZ, SPAIN
[2] UNIV HOSP PRINCIPE ASTURIAS, NEUROL SECT, ALCALA DE HENARES, SPAIN
[3] HOSP PRINCESA, SERV NEUROL, MADRID, SPAIN
[4] HOSP DOCE OCTUBRE, SERV NEUROL, MADRID, SPAIN
[5] UNIV HOSP SAN CARLOS, SERV NEUROL, MADRID, SPAIN
[6] UNIV HOSP SAN CARLOS, SERV GASTROENTEROL, MADRID, SPAIN
[7] HOSP RAMON Y CAJAL, SERV NEUROL, E-28034 MADRID, SPAIN
[8] GEN HOSP, SERV NEUROL, SEGOVIA, SPAIN
关键词
D O I
10.1016/0009-9236(95)90154-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The frequency of five cytochrome P450IID6 allelic variants was studied in deoxyribonucleic acid from 123 patients with Parkinson's disease and 150 healthy volunteers, This was achieved by the use of mutation-specific polymerase chain reaction and restriction fragment length polymorphism, The analyses of the C gamma P2D6 genotype revealed no evidence for a higher prevalence of poor metabolizers among patients with Parkinson's disease. However, increased frequency of patients with Parkinson's disease with the genotype C gamma P2D6wt/C gamma P2D6B was observed, This is attributable exclusively to subjects with early onset of the disease (28 to 49 years), with a relative risk ratio of 4.16 (95% confidence limits, 2.0 to 8.3; p < 0.0005), The subjects who had late-onset Parkinson's disease (greater than or equal to 50 years) had genotypes and C gamma P2D6 allele frequencies similar to the healthy subjects, This indicates that the oxidative polymorphism is related to early-onset but not to late-onset Parkinson's disease. A different influence of C gamma P2D6 genotype on the risk of development of Parkinson's disease is observed in Spaniards, compared with previous findings in British subjects, These results suggest the combined effect of environmental toxins and C gamma P2D6 in the cause of Parkinson's disease.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 57 条
[1]   GENETIC-BASIS FOR DIFFERENCES IN DEBRISOQUIN POLYMORPHISM BETWEEN A SPANISH AND OTHER WHITE-POPULATIONS [J].
AGUNDEZ, JAG ;
MARTINEZ, C ;
LEDESMA, MC ;
LADONA, MG ;
LADERO, JM ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) :412-417
[2]  
AGUNDEZ JAG, 1993, ISSX P, V3, P138
[3]   PARKINSONS-DISEASE - A GENETIC-STUDY [J].
ALONSO, MA ;
OTERO, E ;
DREGULES, R ;
FIGUEROA, HH .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1986, 13 (03) :248-251
[4]   MUTANT DEBRISOQUINE HYDROXYLATION GENES IN PARKINSONS-DISEASE [J].
ARMSTRONG, M ;
DALY, AK ;
CHOLERTON, S ;
BATEMAN, DN ;
IDLE, JR .
LANCET, 1992, 339 (8800) :1017-1018
[5]   THE CYTOCHROME-P450 CYP2D6 ALLELIC VARIANT CYP2D6J AND RELATED POLYMORPHISMS IN A EUROPEAN POPULATION [J].
ARMSTRONG, M ;
FAIRBROTHER, K ;
IDLE, JR ;
DALY, AK .
PHARMACOGENETICS, 1994, 4 (02) :73-81
[6]   FAMILIAL SUBSETS IN IDIOPATHIC PARKINSONS-DISEASE [J].
BARBEAU, A ;
ROY, M .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :144-150
[7]   NEW DATA ON THE GENETICS OF PARKINSONS-DISEASE [J].
BARBEAU, A ;
POURCHER, E .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1982, 9 (01) :53-60
[8]  
BARBEAU A, 1985, LANCET, V1, P747
[9]  
Barbeau A, 1986, ADV NEUROL, V45, P299
[10]   OXIDATIVE POLYMORPHISM OF DEBRISOQUINE IN PARKINSONS-DISEASE [J].
BENITEZ, J ;
LADERO, JM ;
JIMENEZJIMENEZ, FJ ;
MARTINEZ, C ;
PUERTO, AM ;
VALDIVIELSO, MJ ;
LLERENA, A ;
COBALEDA, J ;
MUNOZ, JJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (04) :289-292